Investigation Overview
July 13, 2015 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Regeneron Pharmaceuticals. The investigation by a law firm concerns whether certain Regeneron Pharmaceuticals officers and dire...
You must register (for free) or login to view the entire investigation.